Currently, there are 818.00M common shares owned by the public and among those 810.91M shares have been available to trade.
The company’s stock has a 5-day price change of 12.88% and 5.26% over the past three months. AMAT shares are trading 18.59% year to date (YTD), with the 12-month market performance up to 20.29% higher. It has a 12-month low price of $156.78 and touched a high of $255.89 over the same period. AMAT has an average intraday trading volume of 6.60 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 11.69%, 10.31%, and -2.98% respectively.
Institutional ownership of Applied Materials Inc (NASDAQ: AMAT) shares accounts for 82.45% of the company’s 818.00M shares outstanding.
It has a market capitalization of $156.94B and a beta (3y monthly) value of 1.52. The stock’s trailing 12-month PE ratio is 22.40, while the earnings-per-share (ttm) stands at $8.61. The company has a PEG of 2.06 and a Quick Ratio of 1.87 with the debt-to-equity ratio at 0.35. Price movements for the stock have been influenced by the stock’s volatility, which stands at 2.69% over the week and 2.61% over the month.
Analysts forecast that Applied Materials Inc (AMAT) will achieve an EPS of 2.3 for the current quarter, 2.3 for the next quarter and 10.43 for current fiscal year. The lowest estimate earnings-per-share for the quarter is 2.19 while analysts give the company a high EPS estimate of 2.19. Comparatively, EPS for the current quarter was 2.13 a year ago. Earnings per share for the fiscal year are expected to increase by 7.82%, and 10.94% over the next financial year. EPS should shrink at an annualized rate of 10.89% over the next five years, compared to 24.62% over the past 5-year period.
Looking at the support for the AMAT, a number of firms have released research notes about the stock. KeyBanc Capital Markets stated their Overweight rating for the stock in a research note on January 17, 2025, with the firm’s price target at $225. Morgan Stanley was of a view on December 05, 2024 that the stock is Underweight, while TD Cowen gave the stock Buy rating on November 15, 2024, issuing a price target of $250- $230. Barclays on their part issued Equal Weight rating on June 05, 2024.
